Calimmune's Series B Round

Calimmune raised a round of funding on May 27, 2015.

Calimmune is a clinical-stage biotechnology company focused on developing novel gene therapies that have the potential to improve and protect the lives of patients by enhancing their immune systems. C…

Articles about Calimmune's Series B Round: